Search

everythinglearnresearchcommunity

for

Search:↓

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

Adipose-derived stem cells show promise in treatments but need more research for safety, especially in cancer.

Microneedles can precisely deliver cancer treatments with fewer side effects.

The vitamin D receptor can act without its usual activating molecule, affecting hair growth and skin cancer, but its full range of actions is not well understood.

Plant-derived exosomes can help deliver drugs and enable communication between different organisms.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

High-frequency ultrasonography helps diagnose and manage hair and nail disorders safely and effectively.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Bioelectronic nanogenerators show promise for cancer treatment but need better understanding and development.

Chronic inflammation can cause cancer by making stem cells divide and mutate.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

Understanding molecular processes in skin development is key to creating targeted treatments for skin disorders.

Thymosin β4 helps in cell activities, healing, and organ preservation, and treats hair loss and skin injuries.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

The project created a standardized system for classifying skin lesions in lab rats and mice.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.